Examkin

Soru

Zorluk: KolayCardiovascular System

A patient with a fifty-pack-year smoking history and severe chronic obstructive pulmonary disease comes to the clinic for a routine follow-up. He is seventy-two years old and reports progressively worsening fatigue, bilateral leg swelling, and right upper quadrant abdominal discomfort over the past few months. His current medications include a long-acting muscarinic antagonist and an inhaled corticosteroid. Vital signs show a respiratory rate of 2222/min and an oxygen saturation of 87%87\% on room air. Physical examination reveals elevated jugular venous pressure, a right ventricular heave, and 2+2+ pitting edema of the lower extremities up to the knees. Auscultation of the heart reveals a loud P2P_2. Lung auscultation shows decreased breath sounds globally without wheezes. Which of the following interventions is most likely to improve long-term survival in this patient?

  1. Long-term supplemental oxygen therapyCevap
  2. B
    Intravenous furosemide administration
  3. C
    Scheduled daily nebulized albuterol
  4. D
    Empiric oral levofloxacin therapy
  5. E
    Systemic oral corticosteroid administration

Cevap

Long-term supplemental oxygen therapy
The correct answer provides long-term supplemental oxygen therapy. This patient presents with classic signs of cor pulmonale (right ventricular failure due to pulmonary hypertension from severe COPD). His resting oxygen saturation is markedly low at 87%87\%. In such patients with severe resting hypoxemia (defined as SaO2≤88%SaO_2 \le 88\% or PaO2≤55PaO_2 \le 55 mm Hg), long-term supplemental oxygen therapy (usually ≥15\ge 15 hours per day) is the most important intervention because it is one of the only therapies proven to significantly improve long-term survival. It achieves this by relieving hypoxic pulmonary vasoconstriction, which subsequently lowers pulmonary arterial pressure and decreases right ventricular afterload.

Adım Adım Çözüm

1
Identify the primary clinical syndrome based on the patient's presentation.
The patient has signs of right-sided heart failure (elevated JVP, right ventricular heave, loud P2, hepatomegaly, and peripheral edema) in the setting of severe COPD and chronic hypoxemia, establishing a diagnosis of cor pulmonale.
Recognizing cor pulmonale isolates the cardiovascular consequence of the patient's underlying chronic lung disease.
2
Determine the specific clinical goal requested by the question stem.
The question specifically asks for the intervention that is most likely to improve 'long-term survival'.
Distinguishing between symptomatic relief and mortality-reducing interventions is critical in chronic cardiopulmonary disease management.
3
Select the evidence-based therapy that meets the survival goal for this condition.
Long-term supplemental oxygen therapy is chosen.
In patients with COPD who have severe resting hypoxemia (oxygen saturation ≤88%\le 88\% or arterial PO2≤55PO_2 \le 55 mm Hg), long-term oxygen therapy has been unequivocally shown to prolong survival by reducing hypoxic pulmonary vasoconstriction and right heart strain.

Anahtar Kavram

In patients with cor pulmonale secondary to COPD and severe resting hypoxemia, long-term supplemental oxygen therapy is the primary intervention proven to improve long-term survival.
Bu soruyu puanla

Konular

Cardiovascular System

Bu konudan daha fazla soru